Edition:
India

Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

2.03USD
16 Oct 2019
Change (% chg)

-- (--)
Prev Close
$2.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
41,977
52-wk High
$5.93
52-wk Low
$1.70

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.19 December 17 Oct 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 --
(2) OUTPERFORM 1 1 1 --
(3) HOLD 0 0 0 --
(4) UNDERPERFORM 0 0 0 --
(5) SELL 0 0 0 --
No Opinion 0 0 0 --
Mean Rating 2.00 2.00 2.00 --

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-19 1 2.58 2.58 2.58 --
Quarter Ending Mar-20 1 2.69 2.69 2.69 --
Year Ending Dec-19 1 9.79 9.79 9.79 --
Year Ending Dec-20 1 10.31 10.31 10.31 --
Earnings (per share)
Quarter Ending Dec-19 1 -0.19 -0.19 -0.19 --
Quarter Ending Mar-20 1 -0.20 -0.20 -0.20 --
Year Ending Dec-19 1 -0.89 -0.89 -0.89 --
Year Ending Dec-20 1 -0.87 -0.87 -0.87 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-19 2.41 1.63 0.79 32.59
Quarter Ending Dec-18 3.52 2.59 0.93 26.48
Quarter Ending Sep-18 2.52 2.63 0.11 4.52
Quarter Ending Jun-18 3.01 2.42 0.59 19.57
Quarter Ending Mar-18 1.20 2.69 1.49 124.25

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-19 2.58 2.58 2.58 2.58 --
Quarter Ending Mar-20 2.69 2.69 2.69 2.69 --
Year Ending Dec-19 9.79 9.79 9.79 9.79 --
Year Ending Dec-20 10.31 10.31 10.31 10.31 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-19 0 0 0 0
Quarter Ending Mar-20 0 0 0 0
Year Ending Dec-19 0 0 0 0
Year Ending Dec-20 0 0 0 0
Earnings